NY-ESO-1 protein

NY-ESO-1 recombinant protein

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NY-ESO-1 protein, covering 2017-07-31 to 2021-11-26. Get the full timeline:

Most recent: Clinical Trial Update: NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors [Phase 1]